This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read the article by Boscaro et al¹ with keen interest. Given the fact that Cushing syndrome remains a clinical entity for which many people are screened simply because of uncertainty arising from unusual presentations and limitations of current diagnostic tests, we wish to extend the list of atypical presentations provided in this elegant review.

In a recently published brief report, Lacroix et al² reported an unusual case of 63-year-old woman who developed Cushing syndrome as the result of expression of aberrant adrenocortical receptors responsive to luteinizing hormone, chorionic gonadotropin (with its leuteinizing hormone–like activity), and drugs activating serotonin (5-hydroxytryptamine) receptors (cisapride, metoclopramide). The patient had macronodular adrenal hyperplasia. Long-term treatment with leuprolide acetate led to complete reversal of the syndrome.

There is now an abundance of evidence supporting the role of aberrant or illicit receptors in the possible initiation and/or perpetuation of Cushing syndrome.³ A few years prior to . . . [Full Text of this Article]

RELATED ARTICLE

The Diagnosis of Cushing's Syndrome: Atypical Presentations and Laboratory Shortcomings
Marco Boscaro, Luisa Barzon, and Nicoletta Sonino
Arch Intern Med. 2000;160(20):3045-3053.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pamidronate Reduces Bone Loss after Allogeneic Stem Cell Transplantation
Grigg et al.
J. Clin. Endocrinol. Metab. 2006;91:3835-3843.
ABSTRACT | FULL TEXT